Operationally, the results were in line. The silver lining was an Ebitda (earnings before interest, taxes, depreciation, and amortisation) margin expansion of 266 basis points (bps) over a year, to 19.7 per cent. Savings in advertising costs (down 260 bps to 18 per cent of sales) and raw material costs (down 227 bps to 30.2 per cent) fuelled the expansion. The fall in ad spends is partly due to a high base in the December 2013 quarter, amid higher competition after Procter & Gamble's Oral-B launch.
The oral care category has been under pressure over the past few quarters due to weakening demand. Though, Colgate's volume growth (five per cent) fell short of the Street expectation of six-eight per cent, it is better than peers. Despite already being a leader in the toothpaste segment, the company improved its market share by 80 bps to 56.7 per cent. A large part of the gains were driven by upgrading of toothpowder users to the toothpaste segment. In the toothbrush segment as well, market share increased 80 bps to 42.4 per cent.
The stock had gained almost 10 per cent in less than a month. After the results on Friday, it fell 0.6 per cent to close at Rs 1,911. At these levels, the scrip is trading at 38.2 times the FY16 estimated earnings. While these valuations indicate near-term upsides are limited, analysts remain positive, given the company's strong brand positioning, resilient margins and improving prospects. 'Buy' on declines, they recommended.